Titan Pharmaceuticals Inc (TTNP)

[ZeWaffleBaron]

Used to hold a fair amount of this stock, held through the opioid implant and got out shortly after. Feel that their implant tech is much better for other indications. Not that it doesn't make a solid opioid implant, but the current climate of addiction treatment leads me to believe that it's a product that addicts and docs don't really yet want... for about a million reasons beyond the scope of this msg. I'm excited for the malaria and Parkinson's drugs, but am concerned they will need to dilute to get them through the phases, and that the share price will remain in limbo until dilution is settled. I am planning to re-enter a short while after their next offering, be it 6 weeks or 6 months from now. Not bashing the stock, just bashing the current financials and the reality imposed by the drug they brought to market first, which thankfully finally was approved, and validated their tech. Also interested in post-launch infection stats for the the opioid implant. I don't think it will hold back Parkinson's or malaria, but it will shape the future of the opioid implant. Infection stats for regular docs inserting these post approval, not the infection stats from their own studies. Not saying there will be a difference, just saying I need it proven